English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily reports | Feb 15, 2021

NeuroRx CEO says Zyesami trial shows promising results for critically ill COVID-19 patients

Bree Gonzales | Feb 12, 2021

Aviptadil helped doctor who contracted COVID-19 avoid lung transplant

Bree Gonzales | Feb 12, 2021

Great Plains Health patients treated with Zyesami (aviptadil) show signs of recovery from COVID-19

Press release submission | Feb 12, 2021

ROCHE: Receives first FDA clearance for urine sample type for BK virus quantitative test to aid in the improvement of care for transplant patients

Press release submission | Feb 12, 2021

CARE CAP PLUS: Offers Solution to Benefit Patients and Doctors

Bree Gonzales | Feb 12, 2021

Zyesami (Aviptadil) helped speed recovery for GPH COVID patient

Patient Daily reports | Feb 3, 2021

Promising drug helps Florida man with COVID-19

Michael Pineda | Jan 10, 2021

Pandemic changes the way medical officials approach diabetes

Trending

+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm

+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT

+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'

+ Pharmaceuticals
Patient Daily | May 8, 2025

National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments

  • « First
  • «
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily